Three monthly doses of 60 mg/kg praziquantel for Schistosoma haematobium infection is a safe and effective treatment regimen
Abstract Background Praziquantel (PZQ) is the standard treatment for Schistosomiasis in sub-Saharan Africa. However, there is evidence suggesting praziquantel treatment failure in Schistosome infections with associated potential renal impairment. The objective of this study was to determine the effe...
Main Authors: | Samuel Nkansah Darko, Henry Hanson, Sampson Twumasi-Ankrah, Sandra Baffour-Awuah, Priscilla Adjei-Kusi, Denis Yar, Ellis Owusu-Dabo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12879-020-05053-z |
Similar Items
-
Evidence Against Rapid Emergence of Praziquantel Resistance in Schistosoma haematobium, Kenya
by: Charles H. King, et al.
Published: (2000-12-01) -
Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa
by: Iran Mendonça da Silva, et al.
Published: (2005-07-01) -
Kerentanan Schistosoma japonicum terhadap Praziquantel di Napu dan Lindu, Sulawesi Tengah Indonesia
by: Anis Nurwidayati, et al.
Published: (2016-07-01) -
Kerentanan Schistosoma japonicum terhadap Praziquantel di Napu dan Lindu, Sulawesi Tengah Indonesia
by: Anis Nurwidayati, et al.
Published: (2016-07-01) -
Praziquantel is an effective drug for the treatment of Schistosoma Mansoni infection among school-aged children in Northwest Ethiopia
by: Addisu Tesfie, et al.
Published: (2020-04-01)